A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

NCT03203330 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

535

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Osteoarthritis

Interventions

BIOLOGICAL: TG-C
BIOLOGICAL: Placebo Control

Sponsor

Kolon TissueGene, Inc.